<html>
<head>
<title>With a fresh $10 million in the bank, DotLab hopes to bring endometriosis test to market • TechCrunch</title>
<link href="../Styles/Style.css" type="text/css" rel="stylesheet"/>
</head>
<body>
<h1 class="translated">有了1000万美元的新存款，DotLab希望将子宫内膜异位症测试推向市场TechCrunch</h1>
<blockquote>原文：<a href="https://web.archive.org/web/https://techcrunch.com/2019/07/01/with-a-fresh-10-million-in-the-bank-dotlab-founder-hopes-to-bring-novel-endometriosis-test-to-market/?guccounter=1">https://web.archive.org/web/https://techcrunch.com/2019/07/01/with-a-fresh-10-million-in-the-bank-dotlab-founder-hopes-to-bring-novel-endometriosis-test-to-market/?guccounter=1</a></blockquote><div><header class="article__header ">
	<p class="article__title-wrapper">
						</p><h1 class="article__title translated">有了1000万美元的新存款，DotLab希望将子宫内膜异位症测试推向市场</h1>
		

			
	
			
	</header>

			<div class="article-content">
				<p id="speakable-summary" class="translated">33岁的个性化医药公司<a href="https://web.archive.org/web/20221209125510/https://www.dotlab.com/"> DotLab </a>的创始人希瑟·鲍维尔曼希望用一种她认为更好、更便宜、痛苦更少的子宫内膜异位症检测方法来撼动女性健康产业。</p>
<p class="translated">她的公司刚刚完成了一项由耶鲁大学牵头的验证研究，并从CooperSurgical，TigerGlobal Management，Luxor Capital Group和Wilson Sonsini Goodrich &amp; Rosati律师事务所筹集了1000万美元的首轮融资，以将一种新的非侵入性诊断测试推向市场。</p>
<p class="translated"><img decoding="async" loading="lazy" class="aligncenter size-full wp-image-1850555" title="DotLab DotEndo test" src="../Images/fa5d326a43aee086edc7508e100f04f8.png" alt="DotEndo" srcset="https://web.archive.org/web/20221209125510im_/https://techcrunch.com/wp-content/uploads/2019/06/ABDotLab28593.jpg 2000w, https://web.archive.org/web/20221209125510im_/https://techcrunch.com/wp-content/uploads/2019/06/ABDotLab28593.jpg?resize=150,100 150w, https://web.archive.org/web/20221209125510im_/https://techcrunch.com/wp-content/uploads/2019/06/ABDotLab28593.jpg?resize=300,200 300w, https://web.archive.org/web/20221209125510im_/https://techcrunch.com/wp-content/uploads/2019/06/ABDotLab28593.jpg?resize=768,512 768w, https://web.archive.org/web/20221209125510im_/https://techcrunch.com/wp-content/uploads/2019/06/ABDotLab28593.jpg?resize=680,453 680w, https://web.archive.org/web/20221209125510im_/https://techcrunch.com/wp-content/uploads/2019/06/ABDotLab28593.jpg?resize=1536,1024 1536w, https://web.archive.org/web/20221209125510im_/https://techcrunch.com/wp-content/uploads/2019/06/ABDotLab28593.jpg?resize=1200,800 1200w, https://web.archive.org/web/20221209125510im_/https://techcrunch.com/wp-content/uploads/2019/06/ABDotLab28593.jpg?resize=50,33 50w" sizes="(max-width: 1024px) 100vw, 1024px" data-original-src="https://web.archive.org/web/20221209125510im_/https://techcrunch.com/wp-content/uploads/2019/06/ABDotLab28593.jpg"/></p>
<p class="translated">子宫内膜异位症通常是一种疼痛的疾病，其中组织开始在子宫外生长，并进入女性的卵巢、输卵管和骨盆。根据美国卫生与人类服务部的说法，这种疾病可能会影响多达十分之一的育龄妇女和大约一半的不孕妇女。</p>
<p class="translated">然而，即使有明确的疾病症状，医生也经常试图检查子宫内膜异位症，作为最后的手段。目前唯一的测试方法是通过侵入性的腹腔镜手术，这有内出血、感染和疝气等风险。</p>
<p class="translated">被称为DotEndo的新DotLab测试通过简单的诊断测试消除了这种风险。“使用我们的测试的基本原理是尽可能早地进行测试，并且以非侵入性的方式使用它，”鲍维尔曼告诉TechCrunch。</p>
<p class="translated">这位首席执行官也很快指出DotEndo不是一项基因测试，因为市场上有大量的<a href="https://web.archive.org/web/20221209125510/https://www.dotlab.com/">测试</a><a href="https://web.archive.org/web/20221209125510/https://www.centogene.com/genetic-testing/infertility-testing.html"/><a href="https://web.archive.org/web/20221209125510/https://www.phosphorus.com/blog/phosphorus-one-a-genetic-test-with-real-value-for-your-health"/>帮助女性发现与生育能力有关的可能基因标记。相反，这是医生指定的诊断测试，你可以在实验室进行，以确定你是否患有这种特定的疾病。</p>
<p class="translated">鲍维尔曼在一份声明中说:“DotLab子宫内膜异位症测试背后的革命性技术可以改善受这种令人衰弱的疾病影响的数亿妇女的生活，这种疾病长期以来一直没有得到充分研究和重视。”。</p>
<p class="translated">虽然这个领域最近有了一些创新——美国监管机构<a href="https://web.archive.org/web/20221209125510/https://medicalxpress.com/news/2018-07-fda-pill-pain-endometriosis.html">刚刚批准了一种治疗子宫内膜异位症疼痛的新药</a>——但鲍维尔曼是对的，我们在诊断和治愈这种疾病方面肯定还有很长的路要走，这将在未来从投资者那里获得更多的资本。</p>
<p class="translated">与此同时，DotLab的下一步将是将其测试送到医生手中，希望他们立即向出现症状的患者推荐DotEndo。</p>
			</div>

			</div>    
</body>
</html>